BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5

B-cell receptor (BCR) signaling is essential for the diffuse large B-cell lymphoma (DLBCL) subtype that originates from activated B-cells (ABCs). ABC-DLBCL cells are sensitive to Bruton tyrosine kinase intervention. However, patients with relapsed or refractory ABC-DLBCL had overall response rates f...

Descripción completa

Detalles Bibliográficos
Autores principales: Oien, Derek B., Sharma, Samanta, Hattersley, Maureen M., DuPont, Michelle, Criscione, Steven W., Prickett, Laura, Goeppert, Anne U., Drew, Lisa, Yao, Yi, Zhang, Jingwen, Chan, Ho Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477446/
https://www.ncbi.nlm.nih.gov/pubmed/37184294
http://dx.doi.org/10.1182/bloodadvances.2022009257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477446/
https://www.ncbi.nlm.nih.gov/pubmed/37184294
http://dx.doi.org/10.1182/bloodadvances.2022009257

Ejemplares similares